Article ID Journal Published Year Pages File Type
10910867 Lung Cancer 2015 8 Pages PDF
Abstract
Sorafenib and metronomic oral vinorelbine is active in advanced NSCLC. Baseline levels and changes in DCE parameters and CEC may be useful predictive biomarkers.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer
Authors
, , , , , , , , , , , , , ,